Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Implementation of a culturally competentBMJ open · 2023
   Article
2. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.PloS one · 2022
   Article
3. A focus on the association of Apol1 with kidney disease in children.Pediatric nephrology (Berlin, Germany) · 2021
   Review
4. Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.International journal of molecular sciences · 2020
   Review
5. Kidney international reports · 2019
   Article
6. Association BetweenJournal of the American Heart Association · 2017
   Article
7. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.Kidney international · 2017
   Article
8. KIDNEY DISEASE GENETICS AND THE IMPORTANCE OF DIVERSITY IN PRECISION MEDICINE.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2016
   Article
9. Protein domains of APOL1 and its risk variants.Experimental and molecular pathology · 2015
   Article
10. Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.Experimental and molecular pathology · 2015
    Article
11. Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN).Frontiers in microbiology · 2015
    Review
12. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.American journal of physiology. Renal physiology · 2014
    Article
13. Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.FEBS letters · 2012
    Review

Corrections and comments

• Comment on
  APOL1 localization in normal kidney and nondiabetic kidney disease.2011
• Comment on
  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.2011
• Comment on
  Population-based risk assessment of APOL1 on renal disease.2011
• Comment on
  APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.2011
• Comment on
  Genetic variation in APOL1 associates with younger age at hemodialysis initiation.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as